1. Home
  2. BIRK vs RGEN Comparison

BIRK vs RGEN Comparison

Compare BIRK & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Birkenstock Holding plc

BIRK

Birkenstock Holding plc

HOLD

Current Price

$45.65

Market Cap

8.8B

Sector

N/A

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$160.48

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BIRK
RGEN
Founded
1774
1981
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.8B
8.2B
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
BIRK
RGEN
Price
$45.65
$160.48
Analyst Decision
Strong Buy
Buy
Analyst Count
11
10
Target Price
$67.45
$170.90
AVG Volume (30 Days)
1.8M
724.0K
Earning Date
12-18-2025
10-28-2025
Dividend Yield
N/A
N/A
EPS Growth
178.47
N/A
EPS
1.92
0.03
Revenue
$2,380,334,704.00
$707,890,000.00
Revenue This Year
$18.19
$17.84
Revenue Next Year
$14.16
$12.57
P/E Ratio
$23.67
$6,185.26
Revenue Growth
17.60
11.74
52 Week Low
$38.16
$102.97
52 Week High
$62.66
$182.52

Technical Indicators

Market Signals
Indicator
BIRK
RGEN
Relative Strength Index (RSI) 64.49 51.71
Support Level $42.38 $156.31
Resistance Level $46.37 $165.02
Average True Range (ATR) 1.43 4.73
MACD 0.37 -1.24
Stochastic Oscillator 87.80 25.20

Price Performance

Historical Comparison
BIRK
RGEN

About BIRK Birkenstock Holding plc

Birkenstock Holding PLC is a company that manufactures and sells footbed-based products, including sandals, closed-toe silhouettes, and other products, such as skincare and accessories, for everyday, leisure, and work. It sells its products through two main channels: business-to-business (B2B) which comprises sales made to established third-party store networks, and direct-to-consumer (DTC) which comprises sales made on globally owned online stores through the Birkenstock.com domain and sales made in Birkenstock retail stores. The company's reportable segments are based on its regional hubs and include: the Americas which is also its key revenue-generating segment; Europe; and Australia, Japan, India, China, and the United Arab Emirates (APMA).

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: